ArticleFrontiers in public health2025
Serum trihalomethanes and cognitive decline: investigating environmental risk factors for neurodegenerative diseases.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgrounds: Trihalomethanes (THMs), byproducts of water chlorination, are pervasive in drinking water supplies and have known systemic toxicity. However, their potential neurotoxic effects, particularly on cognitive function, remain poorly understood. This study investigates the association between serum THM concentrations and cognitive decline, aiming to identify environmental risk factors for neurodegenerative diseases. Methods: Data were drawn from the National Health and Nutrition Examination Survey (NHANES) 2011-2014 cohort. A final analytic sample of 743 participants aged 60 years or older was analyzed. Serum concentrations of four THM species-chloroform, bromodichloromethane (BDCM), dibromochloromethane (DBCM), and bromoform (TBM)-were measured. Cognitive performance was assessed using CERAD Word Learning and Delayed Recall, animal fluency test (AFT), and digit symbol substitution test (DSST). Cognitive impairment was defined as scores below the 25th percentile. Multivariate logistic regression, restricted cubic splines (RCS), and subgroup interaction analyses were used to explore associations. Results: Higher serum THM concentrations were significantly associated with increased odds of cognitive impairment. In the fully adjusted model, individuals in the highest quartile of total THMs (TTHMs) had a 2.50-fold higher risk (95% CI: 1.68-3.71) compared to the lowest quartile. RCS analysis revealed a non-linear association between BDCM and cognitive decline, particularly in the AFT. Subgroup analysis indicated that older adults (≥70 years), females, and individuals with hypertension or diabetes were more susceptible to THM-related cognitive impairment. Conclusion: Elevated serum THM levels are independently associated with cognitive impairment, particularly in vulnerable populations. These findings suggest that THMs may act as environmental neurotoxicants contributing to cognitive decline. Public health efforts to reduce THM exposure could play a role in mitigating the risk of neurodegenerative diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.